Key Adverse Events Following Childhood Cancer
The goal of this study is to identify subjects who are more likely to develop a late-occurring complication(s) after undergoing treatment for childhood cancer.
The purpose of this study is to identify key adverse events developing in patients (cases) with a primary cancer diagnosed at age 21 or younger.
- IRB Number: 1011003233 (PHO-COG-FALLON-ALTE03N1)
- Research Study Identifier: TX494
- Principal Investigator: Kamnesh Pradhan, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required